OfficeMax Chair Recall Issued Following Reports of Falls and Injuries

Approximately 216,000 Office Max Task Chairs have been recalled because the backs and base posts can break, which could cause consumers to fall out of the chair and suffer a personal injury.

The U.S. Consumer Product Safety Commission announced the OfficeMax chair recall on September 1, 2009, for “Task Chairs” sold at OfficeMax stores throughout the United States, on their website, out of their catalogs and through direct commercial sales to businesses. The chairs were available between September 2003 and July 2008 for between $40 and $65.

The chair recall was issued after OfficeMax received about 35 reports of the backs or base posts breaking, 15 of those reports involved reports of a personal injury, such as concussions, lacerations, contusions and muscle strains.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall affects Office Max Task Chairs with the model numbers OM182 and OM96614. The chairs are charcoal or dark charcoal in color with black plastic arms and a rolling plastic and metal base. The model number is on a white UPC label located under the seat.

The U.S. CPSC and OfficeMax recommend that customers immediately stop using the chairs and return them for a full refund or a $55 gift card if the customer does not have a receipt.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 2 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.

Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto
Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto (Posted 2 days ago)

Bayer and Monsanto prevailed in a Roundup lawsuit that went to trial in Philadelphia this week, after a jury found that exposure to the herbicide did not cause a man to develop non-Hodgkin's lymphoma.